Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -3.44% 7.025 6.80 7.25 7.375 7.00 7.28 488,968 15:09:56
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.0 -1.5 -0.5 - 27

Eden Research Share Discussion Threads

Showing 7176 to 7196 of 9600 messages
Chat Pages: Latest  288  287  286  285  284  283  282  281  280  279  278  277  Older
DateSubjectAuthorDiscuss
30/5/2019
12:34
good spot super
attyg
30/5/2019
12:02
Eden Research plc@edenresearch The 2019 season in Italy closely resembles 2013 - repeated rains and cold temperatures in spring - leading to high risk of fungal diseases such as #botrytis. Preventative spray programmes are essential. hTTps://www.millevigne.it/index.php/news/635-lo-stop-precoce-alla-botrite-passa-dai-terpeni
supersonico
30/5/2019
09:42
I know a number of people are really fed up with the ongoing lack of value being reflected in the share price. I certainly am. How long, even in a regulatory framework, can one continue with the mantra that these things take time, especially when we have two commercial products, delivered via Sustaine, with Sustaine (we assume, not unreasonably) having successful trials elsewhere with Agrochemical majors and full confirmations still to come alongside commercial arrangements. Mevalone is now a global product as a result of Sipcam's uptake right's. It is, we are told, being used now as a pre-harvest, 'protector'/'insurer' against the possible later onset of Botrytis and it has post harvest viability too. Exempt from MRL & Generally Regarded As Safe (GRAS), Mevalone is the Natural Solution. From a marketing perspective, Eden and Powerscourt have everything to hand here except organic status. This story can run well either with the support of the press or stand alone using video and distribution partners to place in the right channels for understanding and word-of-mouth. Many people should be talking about Eden to the positive and it should create its own direction of travel. This is before we even address Cedroz which has a bigger impact, plus the awaited new products in bigger markets. You can take a definition from wherever you want, I've taken the easiest to find. "The chief executive officer (CEO)[1] or just chief executive (CE), is the most senior corporate, executive, or administrative officer in charge of managing an organization – especially an independent legal entity such as a company or nonprofit institution. CEOs lead a range of organizations, including public and private corporations, non-profit organizations and even some government organizations (e.g., Crown corporations). The CEO of a corporation or company typically reports to the board of directors and is charged with maximizing the value of the entity,[1] which may include maximizing the share price, market share, revenues or another element. In the non-profit and government sector, CEOs typically aim at achieving outcomes related to the organization's mission, such as reducing poverty, increasing literacy, etc. In the early 21st century, top executives typically had technical degrees in science, engineering or law.[2]" From above "The CEO of a corporation or company typically reports to the board of directors and is charged with maximizing the value of the entity,[1] which may include maximizing the share price" I have no issue with Sean's online delivery, nor his connections, nor his IP knowledge and background. I have no basis to, I doubt anyone does. However, he is not maximising the share price. It cannot be argued one day Rodney, when so many days have passed with the result of the above products, relationships and technology. And we have a former high ranking employee of Bayer as our Chairman which doesn't on the face of it after 18 months in situ, appear to be delivering anything of value that we as shareholders can measure. That is fair observation. A CEO has to deliver share price value and that has to be on an ongoing basis, trending upwards and in line with business performance + forward prospects, traditionally measured on a three year timeline. Eden has nothing factored in for the latter and much of its business achievement thus far not factored in to today's share price. It is illogical and unrealistic to expect that one moment in time, yet to come, will catapult the share price north and vertical in an instant and correct all share price performance woes to-date. That if it ever happened, would lead to a mass sell out and a decline in the share price as quick as the incline that occurred. The CEO of Eden has to maximise the share price now and this is an ongoing role and responsibility. it isn't to be implemented when you wish to. It is an ongoing process. NDA's, partners et al do not have the power to supress another's share price and it is unthinkable to imagine this can be so. I know the BoD will read this and other posts and I know they will know who wrote this. I have no ill will towards the BoD, but our CEO whoever that may be an any point in time has to do their utmost to ensure that the share price of today and every day reflects the true value of the Company today. If they truly believe our share price and market cap is fair value right now, then do nothing at circa £23 million. If however this is not what they believe and know value to be, then they need to act to move the share price and show their audience true reasons why the share price should be much higher and therefore why people should invest in it today. This 'moan' by many is not going to go away until it is dealt with. Institutions are not and do not buy into Eden at this level. So they truly have no options but to stir up the market and in due course the hoped for institutions might come on board. Is our current CEO going to be the CEO to put value into the share price today based on current achievements or is another going to be brought into the business to deliver that value today, as well as the ongoing process of creating value for the future, the latter of which I am sure Sean is seeking to achieve.
investingisatrickygame
29/5/2019
14:09
Again, no more 5 a day then. Too dangerous!
investingisatrickygame
29/5/2019
13:02
Looking forward to reading the Farage / Banks /Trump.. Kill em All.. Food and Farming Manifesto. Pesticides explained: the toxic chemicals in up to 70% of produce Studies have linked long-term health issues, while regulators insist breaches of safe limits are rare hTTps://www.theguardian.com/us-news/2019/may/29/pesticides-everyday-products-toxics-guide …………. hTTps://www.ewg.org/news-and-analysis/2019/05/court-docs-monsanto-paid-chemical-industry-front-group-claim-cancer ..//////// BASF collaborates with Rothamsted Research on sustainable agriculture...…….. rather than kill us all ag.. that's nice of them.. hTTps://www.basf.com/global/en/media/news-releases/2019/05/p-19-224.html
supersonico
29/5/2019
10:14
I should have mentioned that my thrust was aimed at Eden's development of post harvest applications.
wan
29/5/2019
09:58
Very interesting research and worrying findings regarding a current fungicide used in post harvest application. The technique developed can be used to detect and assess the penetration of fungicides into fruits and vegetables. Research conducted at the Federal University of Goiás (UFG), in partnership with Louisiana State University, has shown that the imazalil fungicide-type pesticide, apparently one of the most used in post harvest application of fruits and vegetables, penetrates beyond the outer skins in only a matter of days - University creates technique that identifies use of agrochemicals in fruits Privacy Policy 25/05/19 "We found that the substance penetrates beyond the fruit peel, reaching in a short time its internal structures, which can harm the health of the consumer, even if the peel is washed," "Unlike what is said in the specifications of the fungicide, its molecule is not degraded by light and, as a result, it ends up penetrating the fruit," he added, referring specifically to imazalil, used to inhibit fungal growth, postponing rot of product. "Although Brazil does not make use of this fungicide, the technique developed allows us to develop methods on the application of other pesticides, fungicides or agrochemicals in other hortifrutis. In fact, we are already working with tomatoes in a similar approach, "he added. Full story (requires translating) - hTTps://istoe.com.br/universidade-cria-tecnica-que-identifica-uso-de-agrotoxicos-em-frutas/ So, beyond the benefits and sustainability of reducing food waste post harvest, this is also an application that will come under increasing regulatory scrutiny and indeed consumer preference!
wan
28/5/2019
10:25
Eden Research plc@edenresearch Eden Research plc Retweeted NematodeFacts #Cedroz is an innovative new nematicide which targets root knot #nematodes. Eden's encapsulation technology enables #terpenes to be used as an effective, sustainable solution and a valuable part of #IPM. hTTps://twitter.com/NematodeFacts/status/1129552200987041795
supersonico
27/5/2019
13:04
The Green parties had significant/positive results in European elections. Interesting times...
sortudo7
27/5/2019
06:34
Brucie...I would also add the following excerpt from post 420 - I believe the strength of Eden's intellectual property portfolio is already evident in terms of their existing partners involvement and investments, not to mention that those partners have their own 'extensive' patent portfolio's and expertise. Regulatory approvals will further cement that strength and further strengthen Eden's negotiating hand, not to mention strengthen the share price, hence we need to maintain our patience. (END) Followed by an excerpt from the Chairman's AR Statement; "There is potential for an even greater opportunity around the use of Eden’s proprietary, natural micro-encapsulation technology, Sustaine™, which is being tested by a number of third parties, including some of the major agchem companies." Put another way, the products work and there is no effective workaround from a patent perspective. So, there would appear to be 'significant' value locked up in Eden's patent portfolio. So, whilst sales are obviously an important aspect, and the regulatory backdrop another, the patent portfolio is a key enabler, hence the partners commitment and investment to date and indeed the increased interest from third parties in Sustaine. Given the trajectory of product authorisations (and sales) and label extensions, not to mention the advanced pipeline, my guess is that this is also serving to focus the minds of those interested in Sustaine! Again, put another way, with Sustaine's accelerating validation (a very important and overlooked aspect), third parties will almost certainly have to pay handsomely (in one form or another!) to get access to Sustaine. Food for thought; Given the accelerating evidence and validation of Sustaine and indeed the increased interest in Sustaine from third parties, Bayer's 'years' of delay in commercialisation of AH products, is perhaps better put into perspective! Btw, I have not had access to or had any details regarding the Shore Report.
wan
26/5/2019
19:35
All great points, Wan. Yes, indeed, along with rising revenues (hopefully/needfully doubling yoy) we have the current mcap of £21m set against the cost of bring biopesticides to market. Plus interest of Sipcam, Eastman (+Sumi, Bayer etc.) And then the 'addressable market size' today and tomorrow on a CAGR of 17% . With Sustaine as the Great Unknown It's just gonna take some time to come together. Have you had a chance to consider the recent Shore report, either directly or by hearsay?
brucie5
26/5/2019
07:35
Brucie...I think it's perfectly acceptable to keep things conservative, or at least until Eden can explicitly say different! Food for thought;If you consider that the costs of bringing biopesticides to market is around $25-$50m and then consider the role and the necessary investments that have come from Eden's partners, it gives one a level of confidence that target markets are indeed very large and that the targeted market share will thus also be significant. Eastman are the recognised market leader in the control of nematodes, and Cedroz will, at the very least, help them to maintain that. Expiration of approval for Eastman's metam sodium or metam potassium in Europe is 30th July 2022 - hTTp://ec.europa.eu/food/plant/pesticides/eu-pesticides-database/public/?event=activesubstance.detail&language=EN&selectedID=1557 But of course, and as already witnessed by the emergency approval of Cedroz in Italy, demand for a sustainable and safe option is already there....and growing!
wan
24/5/2019
15:42
Yes, 3.5% is a modest ambition, but I just want to keep a handle on the likely minimum prospects here, since, assuming the continued successful rollout of the tech and its products, the investment case will eventually get noticed. Nevertheless, time is a huge factor, and so far, being early has been effectively the same as being wrong... Revenues are from a very low base and take years to develop., Even if the rise is to become exponential, as I hope over next three years. That said, I still think that newsflow over next six months could take us sustainably to the twenties, and then we could have much more interest from investors looking for the next VRS.
brucie5
24/5/2019
15:05
Brucie5, I think a market penetration of 3.5% is way under from my discussions with other shareholders. In a Bio market as you say that has healthy CAGR in its favour, from Eden's very low starting base, from the partners it has, I believe that number is well understated. Shore capital had 5% and look how dismal the share price number was on the back of that. Eden is a tech company and a bigger tech company in the waiting. Sipcam, Bayer et al trials when confirmed as successful should mean Eden is a Crop Protection tech company and should position Eden in a totally different way with significantly higher expectations and market excitement. Little apparent success in Consumer Health and Animal Health and these have been on Eden's Powerpoint presentations for years. they mean nothing at this stage and Eden give them no importance either. Eden needs a refocus/revamp in my opinion. All that gets talked about on here is trends and changing opinion (which is good but is not affecting your wealth to the positive). One could argue Eden is all industry focused and not investment focused. There is no balance and harmony in what they do. If we listen to Eden and we all do, there is no reason given by the Company to invest in today's share price. They give the impression that there is plenty of time to do so and no need to hurry. The share price reflects the same. The story is still not told, nor the opportunity, not the proximity of that investment opportunity. You, wan, Super, AttyG and others on here may understand it, but not enough do and still, therein lies the problem. If the options due in September 2019 pass, the BoD will simply write more, so their position is forever protected from an income and growth perspective. I fail to understand the lack of importance placed on the share price by the Company executives. Livingbridge, Finn and others, private investors cannot and will not I'm sure, accept the dormancy that the BoD allows to persist in the share price. Artemis appear to be selling and whatever their reasons, they're in part, selling. No PR firm, and Powerscourt for all of their global reach has done anything for Eden. Perhaps they might argue that they are constrained monthly fees and remit. If so, Eden is quite able to communicate independently of a PR firm. They are not needed at this stage of Eden's development and no one can say they have been used, successfully. A broker is a regulatory requirement, but one that supports, understands and generates investment in Eden would be welcome. For now and the trend over the last 3-5 years is clear, Eden needs to do the driving of the share price themselves and they need to do it better.
investingisatrickygame
24/5/2019
14:05
Perhaps the Field Crops Trails Cotton/Soybean/Wheat and the IPM note were related?? 2019 Insect Control Recommendations for Field Crops Cotton, Soybean, Field Corn, Sorghum, Wheat and Pasture hTTp://www.utcrops.com/cotton/cotton_insects/pubs/PB1768-Cotton.pdf …………. hTTps://www.upi.com/Health_News/2019/05/24/New-study-links-Roundup-weed-killer-to-liver-damage/4941558707583/?spt=su&;or=btn_tw
supersonico
24/5/2019
08:07
Qian Xuhong ⁦@ECNUER IUPAC 2019@iupac2019 ‘20 years ago, you would hear terrible stories of chinese farmers hurt by highly #toxic pesticides. Now thanks to societal #progress #China has innovating green #pesticides’ says Qian Xuhong @ECNUER on the sofa with ⁦@FemiOke̽7; #iupacNextGen #cropprotection IUPAC 2019@iupac2019 "A lot of effort and resources are invested in China to develop novel and greener #cropprotection products", says Qian Xuhong @ECNUER #iupacNextGen hTTps://twitter.com/iupac2019/status/1131815432334319616 hTTps://twitter.com/iupac2019/status/1131812049661693954 We have about 2000 #cropprotection companies in China, but due to stricter regulation there will be a lot of consolidation in the market and only about 1 to 10% will likely survive", says Qian Xuhong: @ECNUER #iupacNextGen ……………………. Eulogy for the end of the 'Green revolution'. David Zaruk ‘The experts are no longer considered valid, we can’t trust risk assessment anymore, citizen panels will decide whether something can be used or not’ A scary thought @zaruk #blockchain #iupacNextGen #cropprotection hTTps://twitter.com/iupac2019/status/1131822478186242049 hTTps://twitter.com/ResistantAnd/status/1128354085219065861
supersonico
24/5/2019
06:30
A new Report from Innovate UK’s Knowledge Transfer Network that ultimately states "All these factors together suggest that the development of new and safer pest control methods, including alternatives to widely used chemical pesticides, has become a serious priority for the entire agrifood industry." Which most investors in Eden concluded quite some time ago! For a nonetheless interesting read, those interested can download the report here - The future of crop protection Posted on 20/05/2019 hTTps://ktn-uk.co.uk/news/the-future-of-crop-protection
wan
23/5/2019
16:20
I love it when non scientists talk about science based evidence.
chrischas
23/5/2019
08:58
While Bayer still peddle the 'public don't understand' narrative. Despite all the evidence that's come out in the 'discovery' process during the Round up Trials. Are the audience really that ignorant of the trial details?and Monsanto's criminality ? IUPAC 2019@iupac2019 "To better understand the difference between #risk & #exposure, I always explain that if 1 ng of #glyphosate would be found in a1glass of wine, it would still contain 130 million times as much alcohol, which is a proven carcinogenic": @marc_sneyders @Bayer4CropsBE #iupacNextGen What planet are you on V_Andriukaitis ? Monsanto corrupted the 'science' ..that's why they had to ghost write everything . This is common knowledge now. Speaking at @IUPACNextGen @V_Andriukaitis shares his concern that the stated preference of some #spitzenkandidat for banning glyphosate may spell the end of evidence and science based decision making - Should be a concern for every1 @cropprotection #WithOrWithout #ECPAConf2019 …………….. Michal Kicinski@Michal_Kicinski EU Commissioner @V_Andriukaitis underlines the importance of #science and risk communication concerning the approval and use of #pesticides. If we follow public opinion instead of a science based system we will never have food safety in the EU #WithOrWithout #iupacNextGen. ………….. IUPAC 2019@iupac2019 "Scientists should not talk to everyone. The biggest opportunity for science communication lays in the middle and not at the extremes of public opinion! We better focus our energy and attention", says @achood4mu from @Bayer4Crops #iupacNextGen ………………... hTTps://twitter.com/ResistantAnd/status/1128354085219065861
supersonico
23/5/2019
03:11
I'm in the US at the moment and was just watching some TV and an ad came on by a claims firm doing a 'PPI' style no-win-no-fee for anyone who thinks they may have cancer from glyphosate. The whole thing had a huge 'probable human carcinogen' banner and all sorts of wild claims for how much you would get paid out. In the absence of any news from Eden, at least glyphosate is continuing to gather a bad rep..
dplewis1
22/5/2019
21:44
Duke Biopesticides: State of the Art and future opportunities. hTTps://lib.dr.iastate.edu/cgi/viewcontent.cgi?referer=&hxxpsredir=1&article=1303&context=ent_pubs ………………………………………….. New Pesticide Modes of Action from Natural Products agrithority.com/wp/wp-content/uploads/2013/03/Dr.-Duke-USDA.pdf Page 18 ..Mode of Action chart Insecticide. The mode of action describes how the pesticide kills or inactivates a pest. It provides another way of classifying insecticides. Mode of action is important in understanding whether an insecticide will be toxic to unrelated species, such as fish, birds and mammals
supersonico
Chat Pages: Latest  288  287  286  285  284  283  282  281  280  279  278  277  Older
ADVFN Advertorial
Your Recent History
LSE
EDEN
Eden Resea..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200920 15:13:30